December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Identification and Evaluation of Optimal Environment for Maintenance of Encapsulated CNTF Secreting Cell Lines Prior to Intraocular Implantation
Author Affiliations & Notes
  • KA Kauper
    Neurotech USA Lincoln RI
  • S Sherman
    Neurotech USA Lincoln RI
  • P O'Rourke
    Neurotech USA Lincoln RI
  • W Bell
    Neurotech USA Lincoln RI
  • P Stabilia
    Neurotech USA Lincoln RI
  • M Goddard
    Neurotech USA Lincoln RI
  • W Tao
    Neurotech USA Lincoln RI
  • Footnotes
    Commercial Relationships    K.A. Kauper, Neurotech USA E; S. Sherman, Neurotech USA E; P. O'Rourke, Neurotech USA E; W. Bell, Neurotech USA E; P. Stabilia, Neurotech USA E; M. Goddard, Neurotech USA E; W. Tao, Neurotech USA E.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2304. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      KA Kauper, S Sherman, P O'Rourke, W Bell, P Stabilia, M Goddard, W Tao; Identification and Evaluation of Optimal Environment for Maintenance of Encapsulated CNTF Secreting Cell Lines Prior to Intraocular Implantation . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2304.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: The objective of the current study was to examine the role of media volume, feed, gas exchange and incubation time on encapsulated cell performance in vitro and in vivo. Methods: Two genetically modified mammalian cell lines (NTC-201-10 and NTC-201-6A) secreting low and high levels of CNTF were encapsulated within a polymer membrane and placed in holding packages containing either 2, 20 or 40 mL of culture media. The media in the 2 mL volume package was replaced weekly and exposed to 95% humidity and 5% CO 2 . Packages containing 20 and 40 mL of media were closed to the environment with no air headspace and no media replenishmet following closure. All packages were maintained at 37°C for 2-weeks, 1, 2, 3 and 4 months post-encapsulation. At each time point, some of the encapsulated capsules from each treatment group were evaluated for CNTF output and cell viability, and some were surgically implanted into the vitreous of individual eyes of rabbits. After 1 month, the devices were explanted and evaluated for CNTF production and cell viability. Results: Capsules in the 20 and 40 mL closed packages produced higher level of CNTF compared to 2 mL open packages. For the encapsulated NTC-201-10 cell line, CNTF production decreased in the 2 mL and 20 mL packages while remaining steady in the 40 mL group over time. For the encapsulated NTC-201-6A cell line, CNTF production remained steady in the 2 mL package and increased in the 20 mL and 40 mL packages, initially, and reached steady state at two months. In all cases, the CNTF production of explanted capsules were statistically equivalent following a 1-month implantation period. Histological evaluation confirmed that all capsules contained viable cells. Conclusion: Encapsulated CNTF secreting cells can be maintained in a closed environment without media feed and gas exchange. Media volume of 40 mL seems to be ideal for both cell lines. Although some variations in CNTF output were observed after encapsulation in capsules held in vitro, their in vivo performances are consistent.

Keywords: 423 growth factors/growth factor receptors • 629 vitreous • 567 retinal pigment epithelium 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.